Metformin Accumulation and Renal Impairment
Clinical Consequences and Prevention
- The Kidney International guidelines recommend that for patients with eGFR 30-44 mL/min/1.73 m², metformin dose should be reduced to 1000 mg daily to prevent accumulation while maintaining therapeutic benefit 2, 3
- Metformin is contraindicated in patients with eGFR <30 mL/min/1.73 m² because the risk of accumulation and lactic acidosis becomes unacceptably high 2
- For patients with eGFR 45-59 mL/min/1.73 m², dose reduction should be considered if other risk factors for lactic acidosis are present, such as heart failure, liver disease, or alcoholism 2
- The Kidney International guidelines also recommend that eGFR should be monitored at least annually in all patients taking metformin, with increased frequency (every 3-6 months) once eGFR falls below 60 mL/min/1.73 m² 2, 4
- Using serum creatinine alone rather than eGFR to guide metformin dosing can lead to inappropriate continuation in patients with reduced muscle mass, making eGFR a more reliable measure for dosing adjustments 4